Cancer epigenome: A review

Archive of Oncology

Volumn 13, Issue 3-4, 2005, Pages 108-114

  Dimitrijević, Bogomir ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Genome, Human; Neoplasms

Indexed keywords

AGING; CANCER CELL; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHROMATIN; COLON CANCER; CONFERENCE PAPER; CPG ISLAND; GENE ACTIVITY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; METHYLATION; MOLECULAR GENETICS; ONCOGENE; PROSTATE CANCER; PROTEIN MODIFICATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STRATIFICATION; TUMOR SUPPRESSOR GENE;

EID: 33645775744     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0504108D     Document Type: Conference Paper

References (33)

1. Waters MD, Fostel JM. Toxicogenomics and systems toxicology: aims and prospects. Nat Rev Genet 2004;5:936-48.
2. de Hoog CL and Mann M. Proteomics. Annu Rev Genom Hum Genet 2004;5:267-93.
3. Whittield PD, German AJ, Noble PJ. Metabolomics: an emerging post-genomic tool for nutrition. Br J Nutr 2004;92:549-55.
4. Hanash S. Integrated global profiling of cancer. Nat Rev Cancer 2004;4:638-44.
5. Waters MD, Selkirk JK, Olden K. The impact of new technologies on human population studies. Mutat Res 2003;544:349-60.
6. Riggs AD, Porter TN. Overview of epigenetic mechanisms. In: Russo VEA et al, editors. Epigenetic Mechanisms of Gene Regulation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press: 1996. p. 29-45.
7. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Cancer Res 1998;72:141-96.
8. Robertson KD, Wolffe AP. DNA methylation in health and disease. Nature Rev Genet 2000;1:11-9.
9. Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992;69:915-26.
10. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993;366:362-65.
11. Pfeifer GP, Tang M, Denissenko MF. Mutation hotspots and DNA methylation. Current Topics in Microbiology and Immunology 2000;249:1-20.
12. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, et al. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nature Genetics 2000;25:132-8.
13. Baylin SB, Herman JG, Graft JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Cancer Res 1998;72:141-96.
14. Hu JF, Oruganti H, Vu TH, Hoffman AR. The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene. Biochem Biophys Res Com 1998;251:403-8.
15. Barlow D P. Gametic imprinting in mammals. Science 1995;270:1610-3.
16. Reik W, Constancia M, Dean W, Davies K, Bowden L, Murrell A, Feil R, et al. Ig12 imprinting in development and disease. Int J Develop Biol 2000;44:145-50.
17. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP. Relaxation of imprinted genes in human cancer. Nature 1993;362:747-9.
18. Issa JP. CpG-island methylation in aging and cancer. Current Topics in Microbiology and Immunology 2000;249:101-18.
19. Hardison RC. Conserved noncoding sequences are reliable guides to regulatory motifs. Trends in Genetics 2000;16:369-72.
20. Vu TH, Hoffman AR. Comparative genomics sheds light on mechanisms of genomic imprinting. Genome Res 2000;10:1660-3.
21. Wylie AA, Murphy SK, Orton TC, Jirtle RL. Regulatory motifs of the novel imprinted domain. DLKJ/GTL2, mimic those of IGF2/H19. Genome Res 2000;10:1711-8.
22. Laird PW, Jaenisch R. The role of DNA methylation in cancer genetics and epigenetics. Ann Rev Genet 1996;30:441-64.
23. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypemiethylation profile of human cancer. Cancer Res 2001;61:3225-9.
24. Frommer M, McDonald LE, Millar DS, Collis CM, Walt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827-31.
25. Xiong Z, Laird P W. COBRA: a sensitive and quantitative DMA methylation assay. Nucleic Acids Res 1997;25:2532-4.
26. Gonzalgo M, Jones PA. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res 1997;25:2529-31.
27. Herman JG, Graft J R, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
28. Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, et al. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 2002;9:71-6.
29. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000;92:1511-6.
30. Brabender J, Usadel H, Metzger R, Schneider PM, Park J, Salonga D, et al. Quantitative D(6)-methylguanine DNA methyltranslerase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. Clin Cancer Res 2003;9:223-7.
31. Esteller M, Gaidano G, Goodman SN, Zagonel V, Capello D, Botto B, et al. Hypermethylation of the DNA repair gene 0(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002;94:26-32.
32. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000;343:1350-4.
33. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 1998;4:1276-80.